Lung India
Scope & Guideline
Transforming respiratory healthcare with every publication.
Introduction
Aims and Scopes
- Clinical Research in Respiratory Diseases:
The journal publishes original research articles focused on various respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and COVID-19. This research often involves clinical trials, observational studies, and case reports that contribute to the understanding of disease mechanisms and patient care. - Innovative Diagnostic Techniques:
Lung India emphasizes the importance of novel diagnostic methodologies, such as endobronchial ultrasound, imaging techniques, and biomarkers, to improve the accuracy of lung disease diagnosis and management. - Public Health and Epidemiology:
The journal addresses public health issues related to lung diseases, including the epidemiology of respiratory conditions in specific populations, the impact of environmental factors, and strategies for disease prevention and health promotion. - Management Guidelines and Consensus Statements:
The publication frequently features guidelines and consensus statements developed by expert panels to standardize treatment approaches for various lung diseases, ensuring that clinicians have access to the latest recommendations. - Interventional Pulmonology:
Research related to minimally invasive procedures and therapies in pulmonary medicine, including bronchoscopy and thoracoscopy, is a key area of focus, highlighting advancements in patient care.
Trending and Emerging
- COVID-19 Research and Sequelae:
The impact of COVID-19 on lung health has become a dominant theme, with numerous studies addressing acute management, long-term sequelae, and the implications for patients with pre-existing respiratory conditions. - Telemedicine and Remote Monitoring:
The rise of telemedicine as a vital tool for managing respiratory diseases has gained traction, particularly during the pandemic, leading to increased research on its effectiveness and implementation in clinical practice. - Personalized and Precision Medicine:
There is a growing interest in personalized treatment approaches for respiratory diseases, focusing on biomarkers and genetic factors that influence treatment responses, especially in conditions like asthma and COPD. - Management of Drug-Resistant Tuberculosis:
Research on innovative strategies and therapies for managing drug-resistant tuberculosis has increased, reflecting the urgent need to address this global health challenge. - Environmental and Occupational Lung Diseases:
Emerging studies focus on the relationship between environmental exposures, such as air pollution, and lung diseases, emphasizing the need for public health interventions and awareness.
Declining or Waning
- Traditional Tuberculosis Studies:
While tuberculosis remains a significant health issue, there has been a noticeable decline in the number of studies solely focused on traditional tuberculosis treatments and diagnostics, as the field has shifted towards addressing multi-drug resistant strains and co-infections. - General Respiratory Infections:
Research on common respiratory infections, such as pneumonia caused by non-specific pathogens, appears to be waning, possibly due to a greater emphasis on more complex or emerging respiratory diseases such as COVID-19 and its sequelae. - Longitudinal Studies on Non-communicable Diseases:
There has been a reduction in longitudinal studies examining the long-term effects of non-communicable respiratory diseases, as the focus has shifted towards acute respiratory conditions and their immediate management. - Pediatric Respiratory Diseases:
The frequency of research focusing specifically on pediatric respiratory diseases has decreased, potentially due to a growing emphasis on adult respiratory conditions and the impact of COVID-19 on adult populations. - Traditional Clinical Trials for Established Therapies:
The journal has seen fewer articles reporting on traditional clinical trials for established therapies, as there is a shift towards exploring novel therapies and personalized medicine in respiratory care.
Similar Journals
Tuberkuloz ve Toraks-Tuberculosis and Thorax
Elevating knowledge in pulmonary and critical care.Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.
Respiratory Investigation
Connecting scholars to revolutionize respiratory medicine.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
Jornal Brasileiro de Pneumologia
Championing excellence in pulmonary and respiratory research.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
LUNG
Pioneering insights in respiratory health and clinical practice.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
EUROPEAN RESPIRATORY JOURNAL
Fostering Excellence in Respiratory ResearchThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
Pulmonology
Elevating knowledge and practice in pulmonary medicine.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
CHEST
Connecting researchers and practitioners for impactful healthcare solutions.CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.
RESPIROLOGY
Unveiling Breakthroughs in Respiratory HealthRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
RESPIRATORY MEDICINE
Innovating Solutions for Respiratory ChallengesRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
BMC Pulmonary Medicine
Advancing respiratory health through open access research.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.